Woodline Partners’s CONMED CNMD Stock Holding History

Woodline Partners’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-54,192	Closed	-$5.63M	–	655
2023 Q1	$5.63M	Buy	+54,192	New	+$5.24M	0.08%	274

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Woodline Partners's CNMD Position: Q2 2023 in Review

Woodline Partners sold out of CONMED (CNMD) in Q2 2023, closing a stake of 54,192 shares — an estimated $5.63M sold.

Woodline Partners first reported a position in CNMD in Q1 2023 and held it in 1 quarter. The position peaked at $5.63M in Q1 2023. 263 funds tracked by Wall St. Rank hold CNMD as of Q2 2023.

Woodline Partners reported no remaining CONMED position as of Q2 2023 after selling out during the quarter.
Woodline Partners sold 54,192 CONMED shares in Q2 2023, an estimated $5.63M.
Woodline Partners first reported a position in CONMED in Q1 2023 and held it in 1 quarter.
Woodline Partners's CONMED position peaked at $5.63M in Q1 2023.
263 funds tracked by Wall St. Rank held CONMED as of Q2 2023.

Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.